Robust structural, kinetic and biophysical characterization of wild-type human ACOD1, selected mutants and their interaction with citraconate.
Runge, B., Oktay, H., Fucci, I.J., Merten, E.M., Tarasov, S.G., Fan, L., Monteiro, D.C.F.(2026) J Struct Biol X 14: 100157-100157
- PubMed: 42631184 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1016/j.yjsbx.2026.100157
- Primary Citation Related Structures: 
12UX, 12VD, 12VQ, 12VT, 12VW - PubMed Abstract: 
Aconitate decarboxylase 1, an enzyme member of the MmgE-PrpD family of proteins, has gained significant attention in the last decade as a therapeutic target for cancer and inflammatory diseases. Its product, itaconate, is a multifunctional metabolite shown to drive several disease states. Though extensively studied in cellulo and in vivo , this protein is biochemically and mechanistically under characterized and although a family of inhibitors has been described, no ligand-bound structures have yet been determined. In this work we present a thorough structural investigation that yielded the first ligand-bound structure of this protein family, which required the generation of artifact-free apo crystals. We also developed a novel, low-consumption, robust kinetic assay and investigated active site and allosteric mutants to further elucidate structural and dynamic activity relationships of this protein.
- Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
Organizational Affiliation: 
















